Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.6500
+0.0200 (3.17%)
At close: Nov 28, 2025
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 33.69 million as of December 1, 2025. Its market cap has increased by 5.80% in one year.
Market Cap
33.69M
Enterprise Value
30.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 33.69M, an increase of 141.44%. That is a compound annual growth rate of 27.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.50B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.95B |
| Green Thumb Industries | 1.93B |
| Extendicare | 1.72B |
| Cronos Group | 1.31B |
| Trulieve Cannabis | 1.27B |
| WELL Health Technologies | 977.45M |